chronic GRAFT-VERSUS-HOST DISEASE (cGVHD)

GvHD in Focus Risk Factors and Symptoms

This educational video highlights chronic Graft‑versus‑Host Disease (cGvHD), a long‑term complication following allogeneic stem cell transplantation. It outlines key risk factors for cGVHD and demonstrates common clinical manifestations affecting skin, eyes, mouth, lungs, joints, GI tract, scalp, liver, and Fascia. The video emphasizes early recognition to support timely management and improved long‑term outcomes.

TANDEM Meeting 2026

The congress connection: CGvHD and Transplant Key Takeaways in 2026

Between The Lines: GVHD, Episode 2–Skin Manifestation of GVHD – A multidisciplinary Perspective

Skin involvement represents the most frequent and often earliest manifestation of both acute and chronic GvHD, with significant diagnostic and therapeutic implications. In this episode, Dr. Marawan and Dr. Yousef provide a comprehensive, multidisciplinary review of clinical presentation, differential diagnosis, histopathologic correlation, NIH grading criteria, and the functional and quality-of-life impact of cutaneous GvHD. The discussion also addresses challenges in distinguishing chronic skin GvHD from autoimmune mimickers and highlights the importance of early recognition and coordinated care to optimize patient outcomes.

The Congress Connection: cGvHD and Transplant Key Takeaways in 2025

Between The Lines: GVHD, Episode 1 – Understanding the Foundation of Graft vs Host Disease

Tandem Meetings Transplantation and Cellular Therapy Meetings of ASTCT® and CIBMTR®

The Congress Connection: cGvHD and Transplant Key Takeaways in 2025

Molecular Pathway

Optimizing Treatment

Understanding cGVHD

Impact on Patients

Other Treatment Options

Inflammation and Fibrosis Role

Treatment under Clinical Development

Psychological & Economical impact

Clinical outcomes of cGvHD following allogeneic HSCT: A Swedish population-based real-world registry study

European Respiratory Society (ERS)/ European Society for Blood and Marrow Transplantation (EBMT) clinical practice guidelines on treatment of pulmonary cGvHD in adults

Updated European Society of Blood and Marrow Transplantation consensus recommendations for GVHD prophylaxis and management in hematological malignancies after stem-cell transplantation

Advances in the biology of chronic GVHD